In this webinar, Dr. Melodie Weller of University of Utah Health System discusses the epidemiology and screening patterns for Hepatitis Delta Virus in Utah over a 22-year period.
On Thursday 7 March, WHA hosted a panel discussion ahead of International Women’s Day, to explore the unique perspectives of women living with hepatitis. It also celebrated the women that are driving the hepatitis response and supporting other women living with hepatitis.
This infographic from HepVu illustrates hepatitis C treatment restrictions in 2024 and how many states have other requirements that reduce access to hepatitis C care.
The aim of this legal research is to compile enacted state laws and regulations regarding reporting requirements for negative HIV and Hepatitis C test results. The research includes all 50 states as well as the District of Columbia and only covers enacted laws and regulations – excluding proposed bills, sub-regulatory guidance, and case law. Reporting requirements for a specific jurisdiction may vary between health care providers and clinical laboratories. Data displayed within this map excludes provisions specific to prenatal/postnatal testing and exposed newborns – infants.
Tens of thousands of new cases of viral hepatitis occur every year in the United States. Viral hepatitis is a serious public health threat that kills thousands of Americans annually and is a leading cause of liver cancer. Hepatitis A and hepatitis B are vaccine-preventable and hepatitis C can be cured. The Viral Hepatitis Surveillance Report — United States, 2022 presents information from the ongoing, systematic collection, analysis, and interpretation of viral hepatitis-related data.
The Centers for Disease Control and Prevention (CDC) strives to prevent viral hepatitis and eliminate disease and death caused by viral hepatitis. The 2024 Viral Hepatitis National Progress Report provides information on progress toward 2025 goals for new viral hepatitis infections and viral hepatitis–related deaths, overall and for key populations.
In 2019, NASTAD Drug User Health received CDC funding to oversee a demonstration project that would fund syringe services programs (SSPs) to provide patient navigation services for participants. Between 2020 and 2022, eight SSPs around the United States developed and implemented patient navigation services to facilitate engagement with medical and social services for people who use drugs (PWUD).
This is an interactive map from HepVu that demonstrates opioid prescription in the United States in 2021.
This is an interactive map from HepVu that demonstrates overdose mortality in the United States in 2021.
Community health workers can send out this postcard to educate their communities about hepatitis B. The intended audience includes the Micronesian population.
